[SCHEDULE 13G/A] Hagerty, Inc. SEC Filing

Rhea-AI Filing Summary

Hagerty, Inc. Schedule 13G/A discloses that Polar Capital Holdings Plc, Polar Capital LLP and Polar Capital Funds PLC - Biotechnology Fund collectively beneficially owned 5,306,865 shares of Hagerty Class A common stock as of June 30, 2025, representing 5.85% of the class. The filing shows sole voting and dispositive power over the reported shares and corrects a prior submission that had erroneously reported a complete exit. The statement affirms the position is not held to influence control of the issuer.

Positive

• Material disclosure of a 5.85% beneficial ownership position (5,306,865 shares) as of 06/30/2025
• Correction filed to fix an earlier erroneous report, improving regulatory accuracy and market transparency
• Sole voting and dispositive power reported, clarifying who controls the voting and disposition of the shares

Negative

• Prior filing error (previous submission erroneously reported a complete exit), indicating a reporting mistake that required amendment

Insights

Financial Analyst

TL;DR: Institutional holder reports a meaningful 5.85% stake and corrects a prior erroneous exit filing.

The disclosure confirms a material passive stake above the 5% threshold, which can attract investor attention though it does not indicate an intent to influence control. The sole voting and dispositive power reported implies Polar Capital maintains direct authority over these shares. The correction to a prior filing reduces ambiguity about ownership trends between August and June; however, no transaction details such as acquisition dates or cost basis are provided, limiting assessment of intent or performance impact.

Compliance/Risk Analyst

TL;DR: Corrective amendment resolves an internal reporting error, key for regulatory accuracy but not signaling activism.

The amendment clarifies that the earlier August 14, 2025 filing incorrectly reported a full exit. Timely correction is important for regulatory compliance and market transparency. The certification language states the securities were not acquired to change control, which reduces the likelihood of activist intent. From a governance perspective, maintain monitoring for further amendments that could indicate position changes.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

HAGERTY, INC.

(Name of Issuer)

Class A common stock, par value $0.0001 per share

(Title of Class of Securities)

405166109

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 405166109

1

Names of Reporting Persons

Polar Capital Holdings Plc

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,306,865.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 5,306,865.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,306,865.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.85 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. 405166109

1

Names of Reporting Persons

Polar Capital LLP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,306,865.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 5,306,865.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,306,865.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.85 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 405166109

1

Names of Reporting Persons

Polar Capital Funds PLC - Biotechnology Fund

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,306,865.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 5,306,865.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,306,865.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.85 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: HAGERTY, INC.
(b)	Address of issuer's principal executive offices: 121 Drivers Edge, Traverse City, Michigan 49684
Item 2.
(a)	Name of person filing: Polar Capital Holdings Plc Polar Capital LLP Polar Capital Funds PLC - Biotechnology Fund
(b)	Address or principal business office or, if none, residence: 16 Palace Street London, SW1E 5JD George's Court, 54-62 Townsend Street Dublin 2, Ireland
(c)	Citizenship: United Kingdom
(d)	Title of class of securities: Class A common stock, par value $0.0001 per share
(e)	CUSIP No.: 405166109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 5,306,865
(b)	Percent of class: 5.85%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 5,306,865
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 5,306,865
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Information for each Subsidiary is incorporated on the respective cover pages.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Polar Capital Holdings Plc

Signature:	/s/ Nicholas Farren
Name/Title:	Nicholas Farren - Chief Operating Officer
Date:	09/04/2025

Polar Capital LLP

Signature:	/s/ Nicholas Farren
Name/Title:	Nicholas Farren - Chief Operating Officer
Date:	09/04/2025

Polar Capital Funds PLC - Biotechnology Fund

Signature:	/s/ Nicholas Farren
Name/Title:	Nicholas Farren - Chief Operating Officer
Date:	09/04/2025

Exhibit Information

This amendment is being filed as a correction to a previous submission, filed August 14, 2025, which erroneously reported a complete exit of this position. The ownership reported on this form is as of June 30, 2025. Exhibit I JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Polar Capital Holdings PLC By: /s/ Nicholas Farren Name: Nicholas Farren Title: Chief Operating Officer Polar Capital LLP By: /s/ Nicholas Farren Name: Nicholas Farren Title: Chief Operating Officer Polar Capital Funds PLC - Biotechnology Fund By: /s/ Nicholas Farren Name: Nicholas Farren Title: Chief Operating Officer

FAQ

How many Hagerty (HGTY) shares does Polar Capital report owning?

Polar Capital reports beneficial ownership of 5,306,865 shares, representing 5.85% of Hagerty Class A common stock as of 06/30/2025.

Does Polar Capital have voting control over the reported HGTY shares?

Yes. The filing states Polar Capital has sole voting power and sole dispositive power for all 5,306,865 shares.

Why was this Schedule 13G/A filed for HGTY?

This amendment corrects an earlier submission (filed August 14, 2025) that erroneously reported a complete exit; it reports ownership as of June 30, 2025.

Is Polar Capital seeking to influence control of Hagerty?

No. The certification in Item 10 states the securities were not acquired or held to change or influence control of the issuer.

Who signed the filing for Polar Capital?

The filing is signed by Nicholas Farren, Chief Operating Officer, on behalf of Polar Capital Holdings Plc, Polar Capital LLP, and Polar Capital Funds PLC - Biotechnology Fund, dated 09/04/2025.